Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Clinical trial NCT00913133 · COMPLETED
Trial details
- NCT number
- NCT00913133
- Sponsor
- Canyon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-06-01
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.